This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

DaVita Highlights Benefits For Dialysis Patients Who Work

DaVita®, a division of DaVita HealthCare Partners Inc. (NYSE: DVA) and a leading provider of kidney care services, will highlight the benefits of maintaining employment for dialysis patients this week through a social media campaign spanning several platforms.

The United States Renal Data System (USRDS) shows that 50 percent of all dialysis patients are of working age, yet only one in five of those patients work. Additionally, a study showed that two out of three patients who were working in the year prior to dialysis quit their jobs within the first four months of beginning dialysis treatments, a result likely driven by outside pressure and the fear of the unknown.

But, for some patients, that isn’t the case.

“When I learned I had to go on dialysis, I was working at the time. I never even thought that I would stop working,” said Julie Spreckelmeyer, marketing and communications professional and DaVita peritoneal dialysis patient. “My goal was to keep working and to keep up my regular lifestyle.”

DaVita aims to raise awareness of the benefits of continuing to work because research has shown that patients who remain employed are happier, healthier and more likely to get a kidney transplant:
  • Dialysis patients who continue to work after starting treatment are 21 percent less likely to have depression (source)
  • In a study measuring Patient Reported Outcomes, employed ESRD patients scored higher than those who were unemployed in many areas (source)
  • Dialysis patients who maintain employment are twice as likely to get a kidney transplant (source)

Additionally, patients who continue to work also typically describe themselves as more financially secure.

“Social media is yet another channel where we, as a dialysis provider, can educate patients about the benefits of maintaining employment,” said Allen R. Nissenson, M.D., chief medical officer at DaVita. “The benefits of continuing to work are great and with this effort we can help shift the end stage renal disease program back to one of rehabilitation and health, rather than solely maintaining a chronic illness.”

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $95.01 0.00%
FB $99.75 0.00%
GOOG $682.74 0.00%
TSLA $147.99 0.00%
YHOO $27.05 0.00%


Chart of I:DJI
DOW 16,027.05 -177.92 -1.10%
S&P 500 1,853.44 -26.61 -1.42%
NASDAQ 4,283.7530 -79.3910 -1.82%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs